ExploreWatchlistsPricing
  1. JP-listed companies
  2. NIPPON CHEMIPHAR CO., LTD.
  3. Financials
  4. Total payout ratio

NIPPON CHEMIPHAR CO., LTD. (4539)

Market cap
¥6.5B
P/E ratio
91.6x
Nippon Chemiphar manufactures and sells prescription pharmaceuticals while also providing contract safety testing and healthcare services through its subsidiaries.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndTotal payout ratio (Million JPY)YoY (%)
Mar 31, 202136.8-55.96%
Mar 31, 202083.5+101.51%
Mar 31, 201941.4-68.05%
Mar 31, 2018129.7+197.89%
Mar 31, 201743.5-15.16%
Mar 31, 201651.3+139.36%
Mar 31, 201521.4

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat